United Laboratories International Holdings Bilan de santé
Santé financière contrôle des critères 6/6
United Laboratories International Holdings possède un total de capitaux propres de CN¥13.6B et une dette totale de CN¥2.4B, ce qui porte son ratio d'endettement à 18%. Son actif total et son passif total sont CN¥22.8B et de CN¥9.3B. L'EBIT de United Laboratories International Holdings est CN¥3.4B ce qui fait que son ratio de couverture des intérêts -58.1. Elle dispose de liquidités et de placements à court terme de CN¥6.6B.
Informations clés
18.0%
Ratio d'endettement
CN¥2.44b
Dette
| Ratio de couverture des intérêts | -58.1x |
| Argent liquide | CN¥6.55b |
| Fonds propres | CN¥13.57b |
| Total du passif | CN¥9.25b |
| Total des actifs | CN¥22.83b |
Mises à jour récentes de la santé financière
These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely
Nov 11
United Laboratories International Holdings (HKG:3933) Could Easily Take On More Debt
Dec 14Is United Laboratories International Holdings (HKG:3933) A Risky Investment?
Aug 31United Laboratories International Holdings (HKG:3933) Has A Rock Solid Balance Sheet
Dec 23Is United Laboratories International Holdings (HKG:3933) Using Too Much Debt?
Aug 30These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely
Dec 20
Recent updates
These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely
Nov 11The United Laboratories International Holdings Limited (HKG:3933) Stock Catapults 29% Though Its Price And Business Still Lag The Market
Oct 23Here's Why We Think United Laboratories International Holdings (HKG:3933) Is Well Worth Watching
Aug 30Improved Earnings Required Before The United Laboratories International Holdings Limited (HKG:3933) Stock's 26% Jump Looks Justified
Feb 29The United Laboratories International Holdings Limited's (HKG:3933) Low P/E No Reason For Excitement
Jan 04United Laboratories International Holdings (HKG:3933) Could Easily Take On More Debt
Dec 14With EPS Growth And More, United Laboratories International Holdings (HKG:3933) Makes An Interesting Case
Nov 26Is United Laboratories International Holdings (HKG:3933) A Risky Investment?
Aug 31Does United Laboratories International Holdings (HKG:3933) Deserve A Spot On Your Watchlist?
Aug 10United Laboratories International Holdings (HKG:3933) Has A Rock Solid Balance Sheet
Dec 23Are Investors Undervaluing The United Laboratories International Holdings Limited (HKG:3933) By 47%?
Oct 19Is United Laboratories International Holdings (HKG:3933) Using Too Much Debt?
Aug 30Is The United Laboratories International Holdings Limited (HKG:3933) A Smart Pick For Income Investors?
Mar 08The United Laboratories International Holdings (HKG:3933) Share Price Is Up 108% And Shareholders Are Boasting About It
Feb 18The United Laboratories International Holdings Limited's (HKG:3933) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Feb 03Did The United Laboratories International Holdings Limited (HKG:3933) Insiders Sell Shares?
Jan 19We Wouldn't Rely On United Laboratories International Holdings's (HKG:3933) Statutory Earnings As A Guide
Jan 04These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely
Dec 20What Type Of Shareholders Own The Most Number of The United Laboratories International Holdings Limited (HKG:3933) Shares?
Dec 07The United Laboratories International Holdings Limited (HKG:3933) Is Yielding 1.3% - But Is It A Buy?
Nov 23Analyse de la situation financière
Passif à court terme: Les actifs à court terme de 3933 ( CN¥15.1B ) dépassent ses passifs à court terme ( CN¥7.4B ).
Passif à long terme: Les actifs à court terme de 3933 ( CN¥15.1B ) dépassent ses passifs à long terme ( CN¥1.8B ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 3933 dispose de plus de liquidités que de sa dette totale.
Réduire la dette: Le ratio d'endettement de 3933 a été réduit de 70.1% à 18% au cours des 5 dernières années.
Couverture de la dette: La dette de 3933 est bien couverte par le flux de trésorerie opérationnel ( 126.6% ).
Couverture des intérêts: 3933 gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.